Pooled clinical trial analyses evaluating outcomes of HER2-low vs HER2-0 expression in patients with metastatic breast cancer following chemotherapy
2024 · Breast Cancer Research and Treatment · 3 citations
https://doi.org/10.1007/s10549-024-07581-7
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
742
Citations
14
h-index
15
i10-index
Jiezhi Qi is an academic researcher from Dana-Farber Cancer Institute. The author has contributed to research in topics: HIV, Drug Use, Sexual Risk & Homelessness and Social Issues & Opioid Use Disorder Treatment. The author has an h-index of 14, co-authored 17 publications.
Click to start Chat